References
- Agarwal N, Spahr JE, Werner TL, Newton DL, Rodgers GM. Acquired amegakaryocytic thrombocytopenic purpura. Am J Hematol 2006;81:132–135
- Lonial S, Bilodeau PA, Langston AA, Lewis C, Mossavi-Sai S, Holden JT, Waller EK. Acquired amegakaryocytic thrombocytopenia treated with allogeneic BMT: A case report and review of the literature. Bone Marrow Transplant 1999;24:1337–1341
- Cela I, Miller IJ, Katz RS, Rizman A, Shammo JM. Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE). Clin Adv Hematol Oncol 2010;8:806–809
- Kim HD, Boggs DR. A patient with apparent idiopathic a-megakaryocytic thrombocytopenia. Am J Hematol 1980;9:117–120
- Hoffman R. Acquired pure amegakaryocytic thrombocytopenic purpura. Semin Hematol 1991;28:303–312
- Fukushima T, Dong L, Sakai T, Sawaki T, Miki M, Tanaka M, Masaki, Y, Hirose Y, Kuwana M, Umehara H. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus. Lupus 2008;17:210–214
- Marie I, Maurey G, Hervé F, Hellot MF, Levesque H. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Br J Dermatol 2006;155:714–721
- Kuter DJ, Mufti GJ, Bain BJ, Hasserjian RP, Davis W, Rutstein M. Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Blood 2009;114:3748–3756
- Go RS. Idiopathic cyclic thrombocytopenia. Blood Rev 2005;19:53–59
- Lown R, Rhodes E, Bosworth J, Shannon MS, Stasi R. Acquired amegakaryocytic thrombocytopenia: Potential role of thrombopoietin receptor agonists. Clin Adv Hematol Oncol 2010;8:809–812
- Rodeghiero F, Stasi R, Giagounidis A, Viallard J, Godeau B, Pabinger I, Cines D, Liebman H, Wang X, Woodard P. Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: A pooled analysis of 13 clinical trials. Eur J Haematol 2013;91:423–436
- Townsley DM, Desmond R, Dunbar CE, Young NS. Pathophysiology and management of thrombocytopenia in bone marrow failure: Possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes. Int J Hematol 2013;98:48–55